esmeron_2011

13.Amann A., Rieder J., Fleischer M. et al. The influence of Atracurium, Cisatracurium, and Mivacurium on the proliferation of Two Human cell lines in vitro // Anesth. Analg. – 2001. – Vol. 93. – P. 690–696.

14.Andrews J. I., Kumar N., Vandenbrom R. H. G. et al. A large simple randomized trial of rocuronium versus succinylcholine in rapidsequence induction of anaesthesia along with propofol // Acta Anaesthesiol. Scand. – 1999. – Vol. 43. – P. 4–8.

15.Badetti C., Pascal L., Bernini V., Manelli J. C. Resistance to

vecuronium in burn patients Relation between burn size and ED95.

– Ann. Fr. Anesth. Reanim. – 1996. – Vol. 15. – P. 135–141.

16.Baird W. L. M., Savage D. S. Vecuronium; the first years // Clin. – Anaesthesiol. – 1985. – Vol. 3. – P. 347–360.

17.Baraka A. S., Sayyid S. S., Assaf B. A. Thiopental-rocuronium versus ketamine-rocuronium for rapid sequence intubation in parturients undergoing Cesarean section // Anesth. Analg. – 1997. – Vol. 84. – P. 1104–1107.

18.Barash P. G. et al. Muscle relaxants // Handbook of clinical anaesthesia. 2nd ed. / Eds P. G. Barash, B. F. Cullen, R. K. Stoelting. – Philadelphia: Lippincott-Raven, 1992. – P. 186–202.

19.Barclay K., Eggers K., Asai T. Low-dose rocuronium improves conditions for tracheal intubation after induction of anaesthesia with propofol and alfentanil // Brit. J. Anaesthesiol. – 1997. – Vol. 78. – Vol. 92–94.

20.Bartkowski R. R., Witkowski T. A., Azad S. et al. Rocuronium onset of action: a comparison with atracurium and vecuronium // Anesth. Analg. – 1993. – Vol. 77. – P. 574–578.

21.Bartkowski R. R., Witkowski T. A., Azad S. S. et al. Doseresponse and recovery of Org 9426 under enflurane anaesthesia // Anesthesiology. – 1990. – Vol. 73 (Suppl.). – P. A902.

22.Beard K., Jick H. Cardiac arrest and anaphylaxis with anaesthetic agents // JAMA. – 1985. – Vol. 254. – P. 2742.

23.Beaufort A. M., Wierda J. M. K. H., Belapavlovic M. et al. The influence of hypothermia (surface cooling) on the time course action and the pharmacokinetics of rocuronium in humans // Eur. J. Anaesthesiol. – 1995. – Vol. 12 (Suppl. 11). – p. 95–106.

24.Belmont M. R., Lien C. A., Quessy S. et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia // Ibid. – 1995. – Vol. 82. – P.1139–1145.

25.Bevan D. R., Fiset P., Balendran P. et al. Pharmacodynamic behavior of rocuronium in the elderly // Can. J. Anaesthesiol. – 1993. – Vol. 40. – P. 127–132.

26.Booij L. H. D. J., Crul J. F. A comparison of vecuronium with the hypothetical ideal neuromuscular blocking drug: Clinical experiences with Norcuron (Org. NC 45, vecuronium bromide).

81

Symposium, 1983, Apr. 21-22 / Eds S. Agoston, W. C. Bowman,

R.D. Miller, J. Viby-Mogensen. – Geneva; Amsterdam: Excerpta Medica (Current Clinical Practice Series; vol 11), 1983. – P. 3–8.

27.Booij L. H. D. J., Knape H. T. A. The neuromuscular blocking effect of Org 9426; a new intermediately-acting steroidal non-depola- rising muscle relaxant in man // Anaesthesia. – 1991. – Vol. 46. –

P.341–343.

28.Booij L. H. D. J. A dose finding study with rocuronium bromide // Eur. J. Anaesthesiol. – 1994. – Suppl. 11. – P. 16–19.

29.Booth M. G., Marsh B., Bryden F. M. M. et al. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia // Anaesthesia. – 1992. – Vol. 47. – P. 832–834.

30.Bowman W. C., Rodger I. W., Houston J. et al. Structure/action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anaesthetized cat // Anesthesiology. – 1988. – Vol. 69. – P. 57–62.

31.Broek L. van den, Proost J. H., Wierda J. M. K. H. et al. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuroniuminduced neuromuscular block // Eur. J. Anaesthesiol. – 1994. – Vol. 11. – P. 481–487.

32.Broek L. van den, Wierda J. M. K. H., Smeulers N. J. et al. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics //

J.Clin. Anesth. – 1994. – Vol. 6. – P. 288–296.

33.Calon B., Launoy A., Pottecher T. et al. Long-term use of rocuronium in ICU patients with or without multi organ failure // Brit. J. Anaesthesiol. – 1999. – Vol. 82 (Suppl. 1). – P. 164.

34.Cammu G., Coddens J., Hendrickx J., Deloof T. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass // Ibid. – 2000. – Vol. 84. –

P.587–590.

35.Cantineau J. P., Porte F., d’Honneur G., Duvaldestin P. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anaesthetized patients // Anesthesiology. – 1994. – Vol. 81. – P. 585–590.

36.Carroll M. T., Mirakhur R. K., Lowry D. W. et al. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarizing relaxants // Anaesthesia. – 1998. – Vol. 53. – P. 1169–1173.

37.Chetty M. S., Pollard B. L., Wilson A., Healy T. E. J. Rocuronium bromide in dental day case anaesthesia; a comparison with atracurium and vecuronium // Anaesth. Intensive Care. – 1996. – Vol. 24. – P. 37–41.

82

38.Cheymol G. Effects of obesity on pharmacokinetics: Implications for drug therapy // Clin. Pharmacokinet. – 2000. – Vol. 39. – P. 215–231.

39.Chidiac E. J., Raiskin A. O. Succinylcholine and the open eye // Ophthalmol. Clin. N. Amer. – 2006. – Vol. 19, № 2. – P. 279–285.

40.Circeo L. E., Reeves S. T. Multicenter trial of prolonged infusions of rocuronium bromide in critically ill patients: Effects of multiple organ failure // South Med. J. – 2001. – Vol. 94. – P. 36–42.

41.Cooper R., Maddineni V. R., Mirakhur R. K. Clinical study of interaction between rocuronium and some commonly used antimicrobial agents // Eur. J. Anaesthesiol. – 1993. – Vol. 10. – P. 331–335.

42.Cooper R., Mirakhur R. K., Clarke R. S. J., Boules Z. Comparison of intubating conditions after administration of Org 9426 (rocuronium) and suxamethonium // Brit. J. Anaesthesiol. – 1992. – Vol. 69. – P. 269–273.

43.Cooper R. A,. Maddineni V. R., Mirakhur R. K. et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org. 9426) during isoflurane anaesthesia in patients

with and without renal failure // Ibid. – 1993. – Vol. 71. –

P.222–226.

44.Cooper R. A., Mirakhur R. K., Maddineni V. R. Neuromuscular effects of rocuronium bromide (Org. 9426) during fentanyl and halothane anaesthesia // Anaesthesia. – 1993. – Vol. 48. –

P.103–105.

45.Cornet J. P., Abiad M., Coriat P. et al. Evaluation of the effects of rocuronium bromide on haemodynamics and left ventricular function in patients undergoing abdominal aortic surgery // Eur. J. Anaesthesiol. – 1994. – Vol. 11(Suppl. 9). – P. 78–81.

46.Crul J. F., Vanbelleghem V., Buyse L. et al. Rocuronium with alfentanil and propofol allows intubation within 45 seconds // Ibid. – 1995. – Vol. 12 (Suppl. 11). – P. 111–112.

47.Davis L., Jayarajah M. J., Toner C. C., Flynn P. J. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report // Ibid. – 1995. – Vol. 12 (Suppl. 11). –

P.65–68.

48.De Mey J. C., Debrock M., Rolly G. Evaluation of the onset and intubation conditions of rocuronium bromide // Ibid. – 1994. – Vol. 11 (Suppl. 9). – P. 37–40.

49.Demetriou M., Depoix J.-P., Diakite B. et al. Placental transfer of ORG NC45 in women undergoing Caesarean section // Brit. J. Anaesthesiol. – 1982. – Vol. 54. – P. 643–645.

50.Donati F., Meistelman C., Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis // Anesthesiology. – 1991. – Vol. 74. – P. 833–837.

83

51.Donati F., Meistelman C., Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles // Ibid. – 1990. – Vol. 73. – P. 870–875.

52.Donati F. Effect of dose and potency on onset // Anaesth. Pharmacol. Rev. – 1993. – Vol. 1. – P. 34–43.

53.Driessen J. J., Robertson E. N., Egmond J. van, Booij L. H. D. J.

The time-course of action and recovery of rocuronium 0.3 mg. kg- 1 in infants and children during halothane anaesthesia measured with acceleromyography // Paediatr. Anaesth. – 2000. – Vol. 10. –

P.493–497.

54.Dubois M. Y., Lapeyre G., Lea D. et al. Pharmacodynamic effects of three doses of Org 9426 used for endotracheal intubation in humans // J. Clin. Anesth. – 1992. – P. 4. – 472–475.

55.Dubois M. Y., Lea D. E., Kataria B. et al. Pharmacodynamics of rocuronium with and without prior administration of succinylcholine // Ibid. – 1995. – Vol. 7. – P. 44–48.

56.Durant N. N., Marshall I. G., Savage D. S. et al. The neuromuscular and autonomic blocking activities of pancuronium, ORG NC 45, and other pancuronium analogues, in the cat. // J. Pharm. Pharmacol. – 1979. – Vol. 31. – P. 831–836.

57.Dwersteg J. F., Pavlin E. G., Heimbach D. M. Patients with burns are resistant to atracurium // Anesthesiology. – 1986. – Vol. 65. –

P.517–520.

58.Eikermann M., Peters J. Nerve stimulation at 0.15 Hz when compared to 0.1 Hz speeds the onset of action of cisatracurium and rocuronium // Acta Anaesthesiol. Scand. – 2000. – Vol. 44. –

P.170–174.

59.Endo H., Larsen B., Lassen N. A. Regional cerebral blood flow alterations remote from the site of intracranial tumors // Neurosurgery. – 1977. – Vol. 46. – P. 271–281.

60.England A. J., Wu X., Richards K. M. et al. The influence of cold on the recovery of three neuromuscular blocking agents in man // Anaesthesia. – 1996. – Vol. 51. – P. 236–240.

61.Fawcett W. J., Fauvel N. J., Feldman S. A. Comparison of recovery index of rocuronium or vecuronium with simultaneously administered pancuronium in the isolated forearm // Ibid. – 1993.

– Vol. 48. – P. 200–201.

62.Feldman S., Karalliedde L. Drug interactions with neuromuscular blockers // Drug Safety. – 1996. – Vol. 15. – P. 261–273.

63.Fisher D. M., Ramsay M. A. E. et al. Pharmacokinetics of rocuronium during the three stages of liver transplantation // Anesthesiology. – 1997. – Vol. 86. – P. 1306–1316.

64.Fisher M., Munro I. Life-threatening anaphylactoid reactions to muscle relaxants // Anesth. Analg. – 1983. – Vol. 62. – P. 559–564.

84

65.Fisher M. M., Baldo B. A. The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia // Ann. Fr. Anesth. Reanim. – 1993. – Vol. 12. – P. 97–104.

66.Flood P. The importance of myorelaxants in aneswthesia // Curr. Opin. Pharmacol. – 2005. – Vol. 5, № 3. – P. З322–3327.

67.Foldes F. F., Nagashima H., Nguyen H., Ohta Y. The clinical pharmacology of Org. 9426 // Neuromuscular blocking agents: past, present and future: Proc. of the David Savage memorial interface symposium / Eds W. C. Bowman, P. A. F. Denissen, S. Feldman.

–London; Amsterdam: Exerpta Medica, 1990. – P. 171–181.

68.Foldes F. F., Nagashima H., Nguyen H. D., Schiller W. S., Mason M. M. Ohta Y. The neuromuscular effects of Org. 9426 in patients receiving balanced anaesthesia // Anesthesiology. – 1991. – Vol. 75. – P. 191–196.

69.Fuchs-Buder T., Tassonyi E. Intubating conditions and time course of action of rocuronium-induced neuromuscular block in children // Brit. J. Anaesth. – 1996. – Vol. 77. – P. 335–338.

70.Galletly D. C., Treuren B. C. Cutaneous sensitivity to atracurium and vecuronium in patients suffering anaphylactoid reactions to neuromuscular blockers // Anaesth. Intensive Care. – 1985. – Vol. 13. – P.305–310.

71.Grant S., Noble S., Woods A. et al. Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanil // Brit. J. Anaesthesiol. – 1998. – Vol. 81. – P. 540–543.

72.Grundmann U., Mencke T., Soltesz S., Fuchs-Buder T. Onset of properties of rocuronium during co-induction of anaesthesia with desflurane and isoflurane or total intravenous anaesthesia. A randomised, controlled clinical trial // Clin. Drug. Invest. – 2000. – Vol. 20. – P. 351–355.

73.Guay J., Grenier Y., Varin F. Clinical pharmacokinetics of neuromuscular relaxants in pregnancy // Clin. Pharmacokinet. – 1998.

–Vol. 34. – P. 483–496.

74.Gyermek L. Development of ultra short-acting muscle relaxant agents: history, research strategies, and challenges // Med. Res. Rev. – 2005. – Vol. 25, № 6. – P. 610–654.

75.Hans P., Brichant J. F., Franzen A. et al. Comparison of neuromuscular block of atracurium and rocuronium in adults // Acta Anaesthesiol. Belg. – 1996. – Vol. 47. – P. 53–58.

76.Hans P., Franzen A., Falieres X., Brichant J. F. Onset and recovery of neuromuscular block in adults: a comparison between atracurium and rocuronium // Brit. J. Anaesthesiol. – 1995. – Vol. 74 (Suppl.). – P. 87.

77.Hernandez-Palazon J., Tortosa J. A., Martinez-Lage J. F., PerezAyala M. Rocuronium-induced neuromuscular blockade is affect-

85

ed by chronic phenytoin therapy // J. Neurosurg. Anesthesiol. – 2001. – Vol. 13. – P. 79–82.

78.Hofmockel R., Benad G. Time course of action and intubating conditions with rocuronium bromide under propofol-alfentanil anesthesia // Eur. J. Anaesthesiol. – 1995. – Vol. 12 (Suppl. 11).

–Vol. 69–72.

79.Hopkinson J. M., Meakin G., McCluskey A., Baker R. D. Doseresponse relationship and effective time to satisfactory intubation conditions after rocuronium in children // Anaesthesia. – 1997. – Vol. 52. – P. 428–432.

80.Hudson M. E., Rothfield K. P., Tullock W. C., Firestone L. L.

Haemodynamic effects of rocuronium bromide in adult cardiac surgical patients // Can. J. Anaesthesiol. – 1998. – Vol. 45. – P. 139–143.

81.Hughes M., Grant I.S., Biccard B., Nimmo G. Suxamethonium and critical illness polyneuropathy // Anaesth. Intensive Care. – 1999.

–Vol. 27, № 6. – P. 636–638.

82.Huizinga A. C. T., Vandenbrom R. H. G., Wierda J. M. K. H.

Intubating conditions and onset of neuromuscular block of rocuronium (Org. 9426); a comparison with suxamethonium // Acta Anaesthesiol. Scand. – 1992. – Vol. 36. – P. 463–468.

83.Hunter J. M. Histamine release and neuromuscular blocking drugs // Anaesthesia. – 1993. – Vol. 48. – P. 561–563.

84.Jellish W.. S., Brody M., Sawicki K., Slogoff S. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol based anaesthetics // Anesth. Analg. – 2000. – Vol. 91. – P. 1250–1255.

85.Karcioglu O., Arnold J., Topacoglu H. et al. Succinylcholine or rocuronium? A meta-analysis of the effects on intubation condi-

tions // Int. J. Clin. Pract. – 2006. – Vol. 60, № 12. –

P.1638–1646.

86.Khalil M., d’Honneur G., Duvaldestin P. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis // Anesthesiology. – 1994. – Vol. 80. – P. 1241–1247.

87.Khuenl-Brady K. S., Agoston S., Miller R. D. Interaction of Org 9426 and some of the clinically used intravenous anaesthetic agents in the cat // Acta Anaesthesiol. Scand. – 1992. – Vol. 36. –

P.260–263.

88.Khuenl-Brady K. S., Pomaroli A., Puhringer F. et al. The use of rocuronium (Org. 9426) in patients with chronic renal failure // Anaesthesia. – 1993. – Vol. 48. – P. 873–875.

89.Khuenl-Brady K. S., Puhringer F. et al. Evaluation of the time course of action of maintenance doses of rocuronium (Org. 9426)

86

under halothane anaesthesia // Acta Anaesthesiol. Scand. – 1993.

–Vol. 37. – P. 137–139.

90.Klemola U. M., Hiller A. Tracheal intubation after induction of anesthesia in children with propofol-remifentanil or propofol-rocuroni- um // Can. J. Anaesthesiol. – 2000. – Vol. 47. – P. 854–849.

91.Koenig H. M., Hoffman W. E. The effect of anticonvulsant therapy on two doses of rocuronium-induced neuromuscular blockade // J. Neurosurg. Anesthesiol. – 1999. – Vol. 11. – P. 86–89.

92.Kopman A. F., Klewicka M. M., Kopman D. J., Neuman G. G.

Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration // Anesthesiology. – 1999. – Vol. 90. – P. 425–431.

93.Kopman A. F., Klewicka M. M., Neuman G. G. Reexamined: The recommended endotracheal intubating dose for nondepolarizing neuromuscular blockers of rapid onset // Anesth. Analg. – 2001.

–Vol. 93. – P. 954–959.

94.Kopman A. F. Pancuronium, gallamine, and d-tubocurarine compared; is speed of onset inversely related to drug potency? – Anesthesiology. – 1989. – Vol. 70. – P. 915–920.

95.Kumar N., Mirakhur R. K., Symington M. J. J., McCarthy G. J.

Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia // Brit. J. Anaesthesiol. – 1996. – Vol. 77. – P. 488–491.

96.Lam A. M., Pavlin E. G., Visco E., Taraday J. Rocuronium versus succinylcholine-atracurium for tracheal intubation and maintenance relaxation during propofol anesthesia // J. Clin. Anesth. – 2000. – Vol. 12, № 6. – P. 449–453.

97.Lambalk L. M., Wit A. P. M. de, Wierda J. M. K. H. et al. Doseresponse relationship and time course of action of Org. 9426; a new muscle relaxant of intermediate duration evaluated under various anaesthetic techniques // Anaesthesia. –1991. – Vol. 46. – P. 907–911.

98.Larijani G. E., Gratz I., Afshar M. et al. The effect of isoflurane versus balanced anaesthesia on rocuronium’s pharmacokinetics and infusion requirement // Pharmacotherapy. – 1995. – Vol. 15. – P. 36–41.

99Larsen P. B., Hansen E. G., Jacobsen L. S. et al. Intubation conditions after rocuronium or succinylcholine for rapid sequence induction with alfentanil and propofol in the emergency patient // Eur. J. Anaesthesiol. – 2005. – Vol. 22, № 10. – P. 748–753.

100.Laurin E. G., Sakles J. C., Panacek E. A. et al. A comparison of succinylcholine and rocuronium for rapid sequence intubation of emergency department patients // Acad. Emerg. Med. – 2000. – Vol. 7. – Vol. 1362–1369.

87

101.Lavery G. G., Clarke R. S. J., Watkins J. Histaminoid responses to atracurium, vecuronium and tubocurarine // Ann. Fr. Anesth. Reanim. – 1985. – Vol. 4. – P. 180–183.

102.Laxenaire M. C., Gastin I., Moneret-Vautrin D. A. et al. Cross-reac- tivity of rocuronium with other neuromuscular blocking agents // Eur. J. Anaesthesiol. – 1995. – Vol. 12 (Suppl. 11). – P. 55–64.

103.Laxenaire M. C., Mertes P. M. et al. Anaphylaxis during anaesthesia. Results of a two-year survey in France // Brit. J. Anaesthesiol. – 2001. – Vol. 87. – P. 549–558.

104.Levy J. H., Davis G., Duggan J., Szlam F. Determination of the hemodynamics and histamine release of rocuronium (Org. 9426)

when administered in increased doses under N2O/O2-sufentanil anesthesia // Anesth. Analg. – 1994. – Vol. 7. – P. 318–321.

105.Levy J. H. // The development of aminosteroidal neuromuscular blocking agents / Ed. P. A. F. Denissen. –Turnhout: Interface, 1992. – P. 39–41.

106.Loan P. B., Connolly F. M., Mirakhur R. K. et al. Neuromuscular effects of rocuronium in patients receiving beta-adrenoceptor blocking, calcium entry blocking and anticonvulsant drugs // Brit.

J.Anaesthesiol. – 1997. – Vol. 78. – P. 90–91.

107.Lowry D. W., Mirakhur R. K., McCarthy G. J. et al. Neuromuscular effects of rocuronium during sevoflurane, isoflurane and intravenous anaesthesia // Anesth. Analg. – 1998. – Vol. 87. –

P.936–940.

108.Maddineni V. R., McCoy E. P., Mirakhur R. K. et al. Onset and duration of action and hemodynamic effects of rocuronium bromide under balanced and volatile anaesthesia // Acta Anaesthesiol. Belg. – 1994. – Vol. 45. – P. 41–47.

109.Magorian T., Flannery K. B., Miller R. D. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anaesthesia in adult patients // Anesthesiology. – 1993. – Vol. 79. – P. 913–918.

110.Magorian T., Wood P., Caldwell J. et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease // Anesth. Analg. – 1995. – Vol. 80. –

P.754–759.

111.Mann R., Blobner M., Probst R. et al. Pharmacokinetics of rocuronium in obese and asthenic patients-reduced clearance in the obese // Anesthesiology. – 1997. – Vol. 87 (Suppl.). – P. A853.

112.Marshall I. G., Gibb A. J., Durant N. N. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org. NC45) and its potential metabolites in the anaesthetized cat // Brit. J. Anaesthesiol. – 1983. – Vol. 55. –

P.703–714.

88

113.Marshall R. J., Muir A. W., Sleigh T. et al. An overview of the pharmacology of rocuronium bromide in experimental animals // Eur.

J.Anaesthesiol. – 1994. – P. 11 (Suppl. 9). – P. 9–15.

114.Martyn J. A., Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms // Anesthesiology. – 2006. – Vol. 104, № 1. –

P.158–169.

115.Martyn J. A. J., White D. A., Gronert G. A. et al. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers // Anesthesiol. – 1992. – Vol. 76. – P. 822–843.

116.Matteo R. S., Ornstein E., Schwartz A. E. et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org. 9426) in elderly surgical patients // Anesth. Analg . –1993. – Vol. 77. – P. 1193–1197.

117.Matteo R. S., Ornstein E. Effects of age on muscle relaxant // Semin. Anesth. – 1995. – Vol. 14. – P. 35–45.

118.Mayer M., Doenicke A., Hofmann A. et al. The neuromuscular blocking effects of Org. 9426 // Anaesthesist. – 1991. – Vol. 40. –

P.668–671.

119.Mayer M., Doenicke A., Hofmann A., Peter K. Onset and recovery of rocuronium (Org. 9426) and vecuronium under enflurane anaesthesia. – Brit. J. Anaesthesiol. – 1992. – Vol. 69. – P. 511–512.

120.Mayer M., Doenicke A., Lorenz W. et al. Histamine releasing potency of rocuronium // Anesthesiol. – 1992. – Vol. 77 (Suppl.).

– P. A906.

121.Mazurek A. J., Rae B., Hann S. et al. Rocuronium versus succinylcholine: are they equally effective during rapid sequence induction of anaesthesia? // Anesth. Analg. – 1998. – Vol. 87. – P. 1259–1262.

122.McCourt K. C., Salmela L., Mirakhur R. K. et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia // Anaesthesia. – 1998. – Vol. 53. –

P.867–871.

123.McCoy E. P., Connolly F. M., Mirakhur R. K. et al. // Nondepolarizing neuromuscular blocking drugs and train-of-four fade // Can. J. Anaesthesiol. – 1995. – Vol. 42. – P. 213–216.

124.McCoy E. P., Maddineni V. R., Elliott P. et al. Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium // Ibid. – 1993. – Vol. 40. – P. 703–708.

125.McCoy E. P., Mirakhur R. K., Maddineni V. R. et al. Administration of rocuronium (Org. 9426) by continuous infusion and its reversibility with anticholinesterases // Anaesthesia. – 1994. –Vol. 49. – P. 940–945.

126.McCoy E. P., Mirakhur R. K., Maddineni V. R. et al. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia // Brit. J. Anaesthesiol. – 1996. – Vol. 76. – P. 29–33.

89

127.McDonald P. F., Sainsbury D. A., Laing R. J. Evaluation of the onset time and intubation conditions of rocuronium bromide in children // Anaesth. Intensive Care. – 1997. – Vol. 25. – P. 260–261.

128.Meistelman C., McLoughlin C. Suxamethonium – current controversies // Curr. Anaesth. Crit. Care. – 1993. – Vol. 4. – P. 53–58.

129.Meistelman C., Plaud B., Donati F. A comparison of the neuromuscular blocking effects of rocuronium bromide at the adductor pollicis and laryngeal adductor muscles // Eur. J. Anaesthesiol. – 1994. – Vol. 11 (Suppl. 9). – P. 33–36.

130.Meistelman C., Plaud B., Donati F. Rocuronium (Org. 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans // Can. J. Anaesthesiol. – 1992. – Vol. 39. – P. 665–669.

131.Miert M. M. van, Eastwood N. B., Boyd A. H. et al. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis // Brit. J. Clin. Pharmacol. – 1997. – Vol. 44. – P. 139–144.

132.Milavec D., Husedzinovic I. Anaphylactic reaction as a side-effect of administration of general anesthetics and neuromuscular blocking agents // Lijec. Vjesn. – 2006. – Vol. 128, № 9–10. – P. 317–321.

133.Miller D. R., Wherrett Ch., Hull K. et al. Cumulation characteristics of cisatracurium and rocuronium during continuous infusion // Can. J. Anesthesiol. – 2000. – Vol. 47. – P. 943–949.

134.Mills A. K., Martyn J. A. J. Evaluation of atracurium neuromuscular blockade in paediatric patients with burn injury // Brit. J. Anaesthesiol. – 1988. – Vol. 60. – P. 450–455.

135.Mirakhur R. K., Cooper A. R., Maddineni V. R. An evaluation of the interactions of rocuronium bromide with antibiotics // Eur. J. Anaesthesiol. – 1994. – Vol. 11 (Suppl. 9). – P. 103–106.

136.Mirakhur R. K. Safety aspects of neuromuscular blocking agents with special reference to rocuronium bromide // Ibid. – 1994. – Vol. 11 (Suppl. 9). – P. 133–140.

137.Moss J. Muscle relaxants and histamine release // Acta Anaesthesiol. Scand. – 1995. – Vol. 39 (Suppl. 106). – P. 7–12.

138.Motsch J., Leuwer M., Boettiger B. W. et al. Dose-response, timecourse of action and recovery of rocuronium bromide in children during halothane anaesthesia // Eur. J. Anaesthesiol. – 1995. – Vol. 12 (Suppl. 11). – P. 73–78.

139.Muir A. W., Anderson K. A., Pow E. Interaction between rocuronium bromide and some drugs used during anaesthesia // Ibid. – 1994. – Vol. 11 (Suppl. 9). – P. 93–98.

140.Muir A. W., Houston J., Green K. L. et al. Effects of a new neuromuscular blocking agent (Org. 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations // Brit. J. Anaesthesiol. – 1989. – Vol. 63. – P. 400–410.

90